The use of drugs to activate AMPK, including AICAR (146), metformin (147), TZDs (148), berberine (149), and resveratrol (150), can activate skeletal muscle AMPK, improve insulin sensitivity, improve T2D symptoms, and promote lipolysis. This evidence concerns the gene PRKAA2 and type 2 diabetes mellitus.